Recent

% | $
Quotes you view appear here for quick access.

Dendreon Anonim Ortaklik Message Board

  • ron.wallach ron.wallach Jun 28, 2013 10:46 PM Flag

    Now what: The EMA will make its last recommendation to the European Commission in the coming months, with the EC expected to make a final regulatory decision in the second half of 2013. "We are finalizing our plans for a capital-efficient launch in Europe, including evaluating our partnering options," said Chairman and CEO John Johnson. "We look forward to bringing the innovative treatment of PROVENGE to patients around the world."

     

    Now what: The EMA will make its last recommendation to the European Commission in the coming months, with the EC expected to make a final regulatory decision in the second half of 2013. "We are finalizing our plans for a capital-efficient launch in Europe, including evaluating our partnering options," said Chairman and CEO John Johnson. "We look forward to bringing the innovative treatment of PROVENGE to patients around the world."

    Sentiment: Buy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies